Frontlight ResearchEarly access
Trial site
Texas Oncology-Medical City Dallas
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Hodgkin lymphoma1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Fate Therapeutics1 trial
- Incyte Corporation1 trial
- Janssen Research & Development, LLC1 trial
- Loxo Oncology, Inc.1 trial
- NSABP Foundation Inc1 trial
- and 2 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Site data: ClinicalTrials.govUpdated 17 Nov 2026